Registration is open for the BioHorizons Global Symposium, scheduled for April 16-18, 2026, at the Fontainebleau in Miami Beach, Florida. According to the company, the meeting is designed for clinicians and their teams and will feature educational sessions delivered by more than 40 internationally respected speakers.
Programming will center on five areas: advances in hard and soft tissue regeneration; immediate implant therapy and scannable anatomic abutments aimed at improving clinical efficiency and outcomes; developments in full-arch reconstruction, including remote anchorage and FP1 solutions; digital integration in surgical and prosthetic rehabilitation; and strategies for practice growth and clinical outcomes, including a workshop addressing business operations and marketing.
“We are extremely pleased to come to Miami Beach for the iconic BioHorizons Global Symposium,” said Steve Boggan, president and CEO of BioHorizons. “This meeting brings insights from renowned speakers, enriching workshops, and the latest in cutting-edge implant and regenerative technology. Attendees throughout the world will gain valuable skills and enjoy connecting with peers in an unforgettable venue.”
According to the company, attendees can earn 16 continuing education credits through the Scientific Program, with separate registration options available for additional CE-accredited workshops.
“Our focus was to design a program that addresses the real challenges and opportunities implant practitioners face every day,” said Dr. Homa Zadeh, scientific chairman for the Global Symposium. “Attendees can expect an inspiring, immersive educational experience — one that blends scientific rigor, practical innovation and the collective wisdom of leaders shaping the future of implant dentistry.”
The agenda also includes several opportunities for professional networking, including “Havana Nights,” an end-of-symposium celebration planned for Saturday evening.
BioHorizons is headquartered in Birmingham, Alabama, and according to the company, has focused on the development of evidence-based products for dental implant therapy and tissue regeneration since 1994. More information is available at symposium.biohorizons.com.
